- Germline mutations in patients with benign brain tumors are almost as frequent as malignant brain tumors
- Clinician awareness of germline genetic findings among both benign and malignant primary brain tumor cases, and the utilization of genetic testing to assist with appropriate and comprehensive screening are important.